Welcome to the Journal of Pharmacopuncture, an esteemed publication dedicated to advancing the field of pharmacopuncture—a unique approach integrating principles of acupuncture and pharmacology. Published by the Korean Pharmacopuncture Institute in South Korea, this Open Access journal has been a vital resource for researchers and practitioners since 1997. With an impactful presence in the academic landscape, it holds a commendable Q2 ranking in Complementary and Alternative Medicine and a Q3 rank in Pharmacology as of 2023. The journal aims to disseminate groundbreaking research, innovative techniques, and critical reviews that enhance the understanding and applications of pharmacopuncture in modern medicine. As a pivotal source for both academics and industry professionals, the Journal of Pharmacopuncture is key for those eager to explore the intersection of traditional methods and contemporary scientific inquiry.

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Drug Design Development and Therapy is a premier open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of drug discovery, pharmaceutical science, and pharmacology. With an impressive Q1 ranking in its categories as of 2023, this journal is recognized for its significant contributions to the understanding of drug design and therapeutic innovations, making it an invaluable resource for researchers, professionals, and students alike. Established in 2007 and committed to open-access since 2008, the journal provides an inclusive platform for disseminating high-quality research from around the globe. With a robust impact factor and remarkable Scopus rankings, including a 24th place in Pharmaceutical Science and a 48th place in Pharmacology, it reflects a strong percentile performance, ensuring that published articles reach and impact a wide audience. By fostering the exchange of cutting-edge information on drug development and delivery systems, Drug Design Development and Therapy continues to play a crucial role in the ongoing battle against disease, promoting innovative approaches to therapeutic solutions and enhancing patient care.

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

Chinese Medicine is a distinguished open-access journal published by BMC, focusing on the advancement of knowledge and practice in the domain of complementary and alternative medicine. With the ISSN 1749-8546, this journal has established itself as an important resource for researchers, professionals, and students interested in the integration of traditional Chinese medicine with modern scientific practices. Since its inception in 2006, it has garnered a notable reputation, achieving a Q1 ranking in Complementary and Alternative Medicine and Q2 in Pharmacology for 2023, reflecting its high impact and relevance within the academic community. The journal's commitment to disseminating quality research is evident in its Scopus rankings, placing it in the top decile for medicine and pharmacology disciplines. Open access since its launch, Chinese Medicine promotes widespread accessibility and encourages collaborative scholarly efforts in investigating the efficacy and applications of traditional practices in contemporary healthcare. By fostering a platform for rigorous discourse and innovative research, this journal serves as an essential conduit for advancing the understanding of Chinese medicine's role in global health.

Journal of Traditional and Complementary Medicine is a distinguished journal in the field of Complementary and Alternative Medicine, published by Elsevier. With an impressive impact factor, the journal is ranked Q1 in its category and boasts a Scopus ranking of #5 out of 105, placing it in the top 5% of relevant journals globally. Since its inception in 2011, the journal has transitioned to an Open Access model in 2015, ensuring that research is accessible to a wider audience. The journal serves as a critical platform for researchers, healthcare professionals, and students to explore and disseminate information about traditional and complementary treatment modalities, bridging the gap between ancient practices and modern medicine. With its commitment to rigorous peer review and an expansive scope encompassing a range of topics related to traditional medicine, the Journal of Traditional and Complementary Medicine continues to play a pivotal role in advancing understanding and application of alternative therapies in healthcare.

World Journal of Traditional Chinese Medicine, published by Wolters Kluwer Medknow Publications, is a prestigious open-access journal dedicated to advancing the field of Complementary and Alternative Medicine. Since its inception in 2014, this journal has provided a vital platform for researchers, practitioners, and students to share critical insights, original research, and reviews pertaining to Traditional Chinese Medicine (TCM). With an impressive impact factor, placing it in the Q1 category of the 2023 Scopus rankings for Complementary and Alternative Medicine, and ranked #23 out of 105 journals in this discipline, the World Journal of Traditional Chinese Medicine stands as a cornerstone for the promotion and acknowledgment of TCM in the global academic landscape. Operating from India, it fosters a collaborative community of scholars aiming to explore and expand the boundaries of knowledge in holistic health practices. The journal’s open-access model ensures that important research findings are readily accessible, promoting greater dissemination and engagement with traditional medical practices worldwide.

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.